Proportion of flagship products seen increasing

Published: 2004-11-24 07:00:00

Updated: 2004-11-24 07:00:00

Despite the sagging economy, the share of leading OTC products in the total sale of pharmaceutical firms (FY: December) in the third quarter of this year stood at more 10 percent, thus significantly improving the balance sheet of companies owing such products, according to data released by Yakup Shinmoon.

The data found that the three-quarter growth rate of Yuhan Corporation's Beecom-C ros...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.